Diagnostic Update for Covid-19

Authors

DOI:

https://doi.org/10.14295/idonline.v17i68.3828

Keywords:

COVID-19, SARS-CoV-2, Serological tests, Polymerase Chain Reaction Technique, coronavirus, labor diagnosis

Abstract

At the end of 2019, the media cycle was taken over by the news about the coronavirus, soon the whole world was enveloped by the COVID-19 pandemic. According to the New York Times, currently, the number is 4,297,830 deaths worldwide, 202,872,928 total cases. In Brazil, so far, 20,165,672 cases have been registered. Despite the great emergence of this pandemic by the virus caused by SARS-CoV-2 in our country and in the world, several options of diagnostic methodologies have been treated to help us detect this agent, helping to prevent its spread, detecting those who have already had a disease and, in some cases, favoring early treatment. This paper aims at each of these methods, describing how each one of them works in the diagnosis of COVID-19. This work is a bibliographic study, descriptive of the type of integrative literature review, starting from the bibliographic survey and analysisof bibliographic data available from previous researches.

Downloads

Download data is not yet available.

Author Biographies

Thalia Fernanda Araújo Costa, Universidade do Estado de Minas Gerais

Graduação em Biomedicina. Universidade do Estado de Minas Gerais/UEMG

Vanessa Fernandes Mendonça, Universidade do Estado de Minas Gerais/UEMG

Graduação em Biomedicina. Universidade do Estado de Minas Gerais/UEMG.

Thalita Grazielly Santos, Universidade do Estado de Minas Gerais/UEMG

Graduação em Biomedicina. Universidade do Estado de Minas Gerais/UEMG.

Karina Maciel Pádua, Universidade do Estado de Minas Gerais/UEMG.

Graduação em Biomedicina pelo Centro Universitário Barão de Mauá. Especialização em Análises Clínicas e em Citologia Oncótica pela Faculdade Unyleya. Mestra em Desenvolvimento Regional e Meio Ambiente pela Universidade do Estado de Minas Gerais/UEMG.

References

ADENIJI, A. A. Self-collected upper respiratory tract swabs for COVID-19 test’: a feasible way to increase overall testing rate and conserve resources in South Africa. African Journal of Primary Health Care & Family Medicine, v. 12, n. 1, p. 2445, 2021. DOI: https://doi.org/10.4102/phcfm.v12i1.2445

ADHIKARI, S. P.; MENG, S.; WU, Y. et. al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty, v. 9, n. 1, p. 1-12, 2020. DOI: https://doi.org/10.1186/s40249-020-00646-x

AI, T.; YANG, Z.; HOU, H. et. al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, v. 296, n. 2, p. 32-40, 2020. DOI: https://doi.org/10.1148/radiol.2020200642

AMANAT, F.; STALBAUER, D.; STROHMEIER, S. et. al. serological assay to detect SARS-CoV-2 seroconversion in humans. Nature Medicine. v. 26, n. 7, p. 1033-1036, 2020. DOI: https://doi.org/10.1038/s41591-020-0913-5

AMMAD UD DIN, M.; BOPPANA, L. K. T. An update on the 2019-nCoV outbreak.

American Journal of Infection Control, v. 48, n. 6, p. 713, 2020. DOI: https://doi.org/10.1016/j.ajic.2020.01.023

BAIN, W.; LEE, J. S.; WATSON, A. M.; STITT-FISCHER, M. S. Practical Guidelines for

Collection, Manipulation and Inactivation of SARS-CoV-2 and Covid-19 Clinical Specimens.

Current Protocols in Cytometry, v. 93, n. 1, p. 77, 2020.

BEZERRA, V. L.; ANJOS, T. B.; SOUZA, L. E. S. et. al. SARS-CoV-2 como agente

causador da COVID-19: Epidemiologia, características genéticas, manifestações clínicas, diagnóstico e possíveis tratamentos. Brazilian Journal of Health Review. v. 3, n. 4, p. 8452- 8467, jul/ago. 2020. DOI: https://doi.org/10.34119/bjhrv3n4-097

BOSCH, B. J.; ZEE, R. V. D.; HAAN, C. A. M.; ROTTIER, P. J. M. The Coronavirus Spike

Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. Journal of Virology, v. 77, n. 16, p. 8801-8811, 2003. DOI: https://doi.org/10.1128/JVI.77.16.8801-8811.2003

BRASIL, M da S. Vigilância Integral Síndromes Respiratórias Agudas Doença pelo Coronavírus 2019, Influenza e outros vírus Respiratórios, 2020; v.3; p.1-37. Disponível em: <https://www.saude.gov.br/images/pdf/2020/April/06/GuiaDeVigiEp-final.pdf>. Acesso em: 10 de outubro de 2021.

BRASIL. Ministério da Saúde. Protocolo de manejo clínico do coronavírus (COVID-19) na atenção primária à saúde. Secretaria de Atenção Primária à Saúde (SAPS). 2020; Disponível em:

<https://portalarquivos.saude.gov.br/images/pdf/2020/April/08/20200408protocoloManejov er07.pdf>. Acesso em: 10 de outubro de 2021.

BRASIL. Ministério da Saúde. Secretaria de Atenção Especializada à Saúde. Departamento de Atenção Hospitalar, Domiciliar e de Urgência. Protocolo de Tratamento do Novo Coronavírus (2019-nCoV). Brasília, 2020.

BRASIL. Ministério da Saúde. SECRETARIA DE CIÊNCIA, TECNOLOGIA IEIEES.

Acurácia dos testes diagnósticos registados na ANVISA para a COVID-19. Acurácia dos testes diagnósticos registrados na ANVISA para a COVID-19, p. 1-35, 2020.

CABRAL, P.; GOMES, B.; FELGEURIAS, M. Certezas Incertas: Desafios proximos no Diagnostgico Laboratorial da COVID-19. Acta Medica Portuguesa, v. 34, n. 1, p. 3-5, 2021. DOI: https://doi.org/10.20344/amp.15002

CAI, J.; JIN, X.; DAOJIONG, L. et. al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clinical Infectious Diseases, v. 71, n. 6, p. 1547-1551, 2020. DOI: https://doi.org/10.1093/cid/ciaa198

CDC. Coronavírus Disease 2019 (COVID-19). 2020. Disponível em:

<https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.html.>. Acesso em: 10 de outubro de 2021.

CDC. Guidance on Interpreting Covid-19 Test Results. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. 2020. p. 19. Disponível em:

<https://www.whitehouse.gov/ wp-content/uploads/2020/05/Testing-Guidance.pdf> Acesso em: 10 de outubro de 2021.

CDC. Interim Guidelines for COVID-19 Antibody Testing. 2020. Disponível em:

<https://www.cdc.gov/ coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html> Acesso em: 10 de outubro de 2021.

CDC-Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for Covid-19. 2020 Disponível em:

<https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical- specimens.html#specimen> Acesso em: 10 de outubro de 2021.

CHAN, J.; YUAN, S.; KOK, K. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, v. 395, n. 10223, p. 514-523, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30154-9

CHENG, M. P.; PAPENBURG, J.; DESJARDINS, M. et. al. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review. Annals of Internal Medicine, v. 172, n. 11, p. 726-734, 2020. DOI: https://doi.org/10.7326/M20-1301

CUI, Y.; TIAN, M.; HUANG, D. et. al. A 55-Day-Old Female Infant Infected with 2019 Novel Coronavirus Disease: Presenting with Pneumonia, Liver Injury, and Heart Damage. The Journal of Infectious Diseases, v. 222, n. 11, p. 1775-1781, 2020. DOI: https://doi.org/10.1093/infdis/jiaa113

DALL’AGNOL, J.; SHAWARTZ, E.; LISE, F. Recommendations for specimen collection for detection and diagnosis of COVID-19. ABCS HEALTH SCIENCES, v.46, 2021. DOI: https://doi.org/10.7322/abcshs.2020195.1642

DATE, R. Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. 2020. Disponível em: <https://www.cdc.gov/coronavirus/2019- ncov/lab/faqs.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus 2F 2019-ncov%2Flab%2Flab-testing-faqs.html> Acesso em: 10 de outubro de 2021.

DIAS, V. M. C. H.; CARNEIRO, M. VIDAL, C. F. L.; et al. Orientações sobre Diagnostico, Tratamento e Isolamento de Pacientes com COVID-19. Journal of Infection Control, v. 9, n.2, abr./jun. 2020.

DIAS, V. M. C. H.; CARNEIRO, M.; MICHELIN, L.; et. el. Testes sorológicos para COVID- 19: Interpretação e aplicações práticas. Journal of Infection Control, v. 9, n. 2, Abr/Jun, 2020.

DIAS. V.; CARNEIRO, M.; VIDAL, C.; CORRADI, M.; BRANDÃO, D.; CUNHA, C. et al

Orientações sobre Diagnóstico, Tratamento e Isolamento de Pacientes com COVID-19.

Journal of Infection Control, v. 9, n. 2, Abr./Jun. 2020.

ERNST, D. J.; MARTEL, A. M.; ARBIQUE, J. C. et. al. Collection of Diagnostic Venous Blood Specimens. Clinical and Laboratory Standards, v. 37, n. 7, p. 1-60, 2017.

Estado do Rio Grande do Sul. Secretaria da Saúde do Rio Grande do Sul. Centro Estadual de Vigilância Sanitária. Orientações para coleta e transporte de secreção respiratória- 2020.

Disponivel em: <https://saude.rs.gov.br/upload/arquivos/202002/06115208-2020-orientacoes- coleta-amostra-coronavirus-anexo-plano.pdf> Acesso em: 10 de outubro de 2021.

FERGUSON, N. M.; LAYDON, D.; GILANI-NEDJATI, G et. al. Impact of non-

pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand.2020.Disponível em:

<https://spiral.imperial.ac.uk:8443/bitstream/10044/1/77482/14/2020-03-16-COVID19- report- 9.pdf>. Acesso em: 10 de outubro de 2021.

FERREIRA, C. E. S. Métodos Laboratoriais para Diagnóstico da Infecção pelo SARS-CoV- 2.Vol. 105. Sociedade Brasileira de Patologia Clínica; 2020. Disponível em:<http://www.bibliotecasbpc.org.br/index.php?P=4&C=0.314.345> Acesso em: 10 de outubro de 2021.

GUAN, W.; NI, Z.; HU, Y.; et. al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, v. 382, p. 1708-1720, 2020. DOI: https://doi.org/10.1056/NEJMoa2002032

HAAS, D. J.; TORRES, A, C, D. Aplicações das técnicas de PCR no diagnóstico de doenças infecciosas dos animais. Revista Científica De Medicina Veterinária, v. 26, 2016.

HOFFMAN, T.; NISSEN, K.; KRAMBRICH, J.; et. al. Evaluation of a COVID-19 IgM and

IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2. Infection Ecology & Epidemiology, v. 10, n. 1, 2020. DOI: https://doi.org/10.1080/20008686.2020.1754538

HUANG, C.; WANG, Y.; LI, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497-506, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

IAEA-INTERNATIONAL ATOMIC ENERGY AGENCY. How is the COVID-19 virus

detected using real time RT–PCR? 2020. Disponível em:

<https://www.iaea.org/bulletin/infectious-diseases/how-is-the-covid-19-virus-detected-using- real- time-rt-pcr>. Acesso em: 10 de outubro de 2021.

JIN, Y.; CAI, L.; CHENG, Z.; et. al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, v. 7, n. 1, p. 4, 2020.

LAN, J.; GE, J.; YU, J.; et. al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, v. 581, n. 7807, p. 215-220, 2020. DOI: https://doi.org/10.1038/s41586-020-2180-5

LANG, P. Fiocruz detecta mutação associada a variantes de preocupação no país, 2021. Disponível em: <https://portal.fiocruz.br/noticia/fiocruz-detecta-mutacao-associada- variantes-de-preocupacao-no-pais> Acesso em: 06 de agosto de 2021.

LI, R.; PEI, S.; CHEN, B.; YIMENG, S, ZHANG, T. YANG, W.; SHAMAN, J. Substantial

undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV- 2). Science, v. 368, n. 6490, p. 489-493, 2020. DOI: https://doi.org/10.1126/science.abb3221

LI, Z.; YI, Y.; LUO, X.; et. al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Journal of Medical Virology, v. 92, n. 9, p. 1518-1524, 2020. DOI: https://doi.org/10.1002/jmv.25727

LIANG, W.; GUAN, W.; CHEN, R.; WANG, W.; LI, J.; XU, K.; LI, C.; AI, Q.; LU, W.;

LIANG, H.; LI, S.; HE, J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology, v. 21, n. 3, p. 335-337, 2020. DOI: https://doi.org/10.1016/S1470-2045(20)30096-6

LIU, T.; HU, J.; XIAO, J.; et. al. Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China. BioRxiv, 2020. DOI: https://doi.org/10.1101/2020.01.25.919787

LONG, Q. X.; LIU, B. Z.; DENG, H. J.; et. al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine, v. 26, p. 845-848, 2020;

LV, H.; WU, N. C.; TSANG, W. T. Y.; et. al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. bioRxiv, 2020. DOI: https://doi.org/10.1101/2020.03.15.993097

MAGNO, L.; ROSSI, T. A.; LIMA, F. W. M.; SANTOS, C. C.; CAMPOS, G. B.; MARQUES, L. M.; PEREIRA, M.; PRADO, N. M. B. L.; DOURADO, I. Desafios e

propostas para ampliação da testagem e diagnostico para COVID-19 no Brasil. Ciência e Saude Coletiva, v. 25, n. 9, p. 3355-3364, 2020. DOI: https://doi.org/10.1590/1413-81232020259.17812020

MARTINELLO, F. Acuracia diagnostic dos metodos sorologicos de detecção da COVID-19.

Revista Brasileira de Analises Clinicas, v. 53, n. 2, p. 155-162, 2021. DOI: https://doi.org/10.22201/fesa.figuras.2021.2.3.166

MCINTOSH, K. Coronavirus disease 2019 (COVID-19). 2020. Disponível em: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19. Acesso em: 10 de outubro de 2021.

MEHTA, P.; MCAULEY, D. F.; BROWN, M.; SANCHEZ, E.; TATTERSALL, R. S.;

MANSON, J. J. COVID-19: consider cytokine storm syndromes and immunosuppression.

Lancet, v. 395, n. 10229, p. 1033, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30628-0

MELLO, F. C; COSTA, J. F. The utility of molecular biology in the diagnosis of tuberculosis.

Jornal Brasileiro de Pneumologia. v. 31, n. 03, 2005.

MENEZES, M. E.; LIMA, L. M.; MARTINELLO, F. Diagnostico laboratorial do SARS- CoV-2 por transcrição reversa seguida de reação em cadeia da polimerase em tempo real (RT- PCR). Revista Brasileira de Analises Clinicas, v. 52, n. 2, p. 122-130, 2020. DOI: https://doi.org/10.21877/2448-3877.20200006

MONTESINOS, I.; GRUSON, D.; KABAMBA, B.; et. al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. Journal Clinical Virology, v. 128, 2020. DOI: https://doi.org/10.1016/j.jcv.2020.104413

MURTHY, S.; GOMERSALL, D. C.; FOWLER, A. R. Care for critically ill patients with COVID-19. JAMA, v. 323, n. 15, p. 1499-1500, 2020. DOI: https://doi.org/10.1001/jama.2020.3633

NALLA, A. K.; CASTO A. M.; HUANG, M. L. W.; et al. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit. Journal of Clinical Microbiology, v. 58, n. 6, jun. 2020 DOI: https://doi.org/10.1128/JCM.00557-20

NETO, A. G. S.; SANTOS, A. F.; SANTOS, J. R.; ALVES, L. L.; RAMOS, A. C. S.; SANTANA, A. A. M.; SANTOS, I. D. D.; GASPAR, L. M. A. C. COVID-19: Metodologia

de diagnóstico. Research, Society and Development. v. 10, n. 5, 2020.

NOGUEIRA, J. M. R.; SILVA, L. O. P. Diagnostico laboratorial da COVID-19 no Brasil.

Revista Brasileiroa de Analises Clinicas, v. 52, n. 2, p. 117-112, 2020.

OMS. Clinical management of severe acute respiratory infection (SARI) when COVID- 19 disease is suspected: interim guidance, 13 March 2020. Acesso em: 10 de outubro de 2021.

OMS. Coronavirus disease (COVID-19) advice for the public: When and how to use masks, 2020. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/advice-for-public/when-and-how-to-use-masks. Acesso em: 10 de outubro de 2021.

OMS. Coronavirus disease 2019 (COVID-19): Situation Report – 73.2020. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73- covid- 19.pdf?sfvrsn=5ae25bc7_2.> Acesso em: 10 de outubro de 2021.

OMS. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human

cases. 2020. Disponível em: https://www.who.int/publications-detail/laboratory-testing-for- 2019-novel-coronavirus-in-suspected-human-cases-20200117. Acesso em: 10 de outubro de 2021.

PHELAN, A. L.; KATZ, R.; GOSTIN, L. O.; The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA, v. 323, n. 8, p. 709-710, 2020. DOI: https://doi.org/10.1001/jama.2020.1097

PINHO, J. R. R.; OLIVEIRO, K. G.; SITNIK, R.; MALUF, M. M.; RODRIGUES, P. H. S.;

SANTANA, R. A. F.; WELTER, E. R.; IRONY, O. Infecção persistente de longo prazo pelo coronavirus SARS-CoV-2. Einstein, v. 19, p. 1-5, 2021.

PORTE, L.; LEGARRAGA, P.; VOLLRATH, V.; et. al. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. International Journal of Infectious Diseases, v. 99, p. 328-333, 2020; DOI: https://doi.org/10.1016/j.ijid.2020.05.098

REIS, A. A. S.; SANTOS, R. S. O padrão ouro no diagnóstico molecular na COVID-19: O que sabemos sobre a soberania deste método? Brazilian Journal of Health Review. Curitiba, v. 3, n. 3, p. 5986-5992, maio/junho, 2020. DOI: https://doi.org/10.34119/bjhrv3n3-157

ROSA, S. G. V.; SANTOS, W. C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Saúde Pública, v. 44, p. 40, 2020. DOI: https://doi.org/10.26633/RPSP.2020.40

ROTHAN, H. A.; BYRAREDDY, S. N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, v. 109, p. 102433, 2020. DOI: https://doi.org/10.1016/j.jaut.2020.102433

RUSSELL, D. C.; MILLAR, E. J.; BAILLIE, K. J. Clinical evidence does not support corticosteroid treatment for 2019-CoV lung injury. The Lancet, v. 395, n. 10223, p. 473-475, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30317-2

SAIKI, R. K.; GELFAND, D. H.; STOFFEL, S.; SCHARF, S. J.; HIGUCHI, R.; HORN, G.

T.; MULLIS, K. B.; ERLICH, H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. v. 239, n. 4839, p. 487-91, Jan, 1988. DOI: https://doi.org/10.1126/science.239.4839.487

SANTOS, C, F.; SAKAI, V. T.; MACHADO, M. A. A. M.; et. al. Reverse transcription and polymerase chain reaction: principles and applications in dentistry. Journal of Applied Oral Science. v.12. n.1, 2004. DOI: https://doi.org/10.1590/S1678-77572004000100002

SANTOS, V. A.; RAFAEL, M. M.; SABINO, E. C.; et. al. Sensitivity of the Wondfo One Step COVID-19 test on using serum samples. Clinics, v. 75, p. 19-20, 2020. DOI: https://doi.org/10.6061/clinics/2020/e2013

SBAC-Sociedade Brasileira de Análises Clínicas. Métodos laboratoriais para diagnóstico da COVID-19. 2020 Disponível em: <https://www.sbac.org.br/blog/2020/03/25/metodos- laboratoriaispara-diagnostico-da-covid-19/> Acesso em: 10 de outubro de 2021.

SETHURAMAN, N.; JEREMIAH, S. S.; RYO, A.; Interpreting Diagnostic Tests for SARS- CoV-2. JAMA, v. 323, n. 22, p. 2249-2251, 2020. DOI: https://doi.org/10.1001/jama.2020.8259

SHANG, J.; YE. G.; SHI, K.; et. al. Structural basis of receptor recognition by SARS-CoV-2.

Nature, v. 581, n. 7807, p. 221-224, 2020. DOI: https://doi.org/10.1038/s41586-020-2179-y

SINGHAL, T. A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics, v. 87, n. 4, p. 281-286, 2020. DOI: https://doi.org/10.1007/s12098-020-03263-6

SOUSA, F. C. B; SILVA, L. C. N. T.; SOUSA, M. A. A.; SANTANA, M. A. A., SILVA, R.

B. Protocolos utilizados para diagnósticos de COVID-19. Revista da FAESF, vol. 4, p. 35- 39, Junho, 2020.

SOUSA, F. C.; SILVA, L. C. N. T.; SOUSA, M. A. A.; et. al. Protocolos utilizados para diagnóstico de COVID-19. Revista da FAESF, v. 4, p. 35-39, 2020. DOI: https://doi.org/10.58969/25947125.4.0.2020.113

SOUTO, X. M. COVID-19: Aspectos gerais e implicações globais. RECITAL - Revista de Educação, Ciência e Tecnologia de Almenara, v. 2, n. 1, p. 12-36, jan/abr. 2020. DOI: https://doi.org/10.46636/recital.v2i1.90

Stanford Health Care. Covid-19 Specimen Collection & Handling: Covid-19 Sars-CoV-2 RT-PCR molecular testing. 2020 Disponível em: <https://stanfordhealthcare.org/health- care-professionals/covid-19-test/covid-19-olecular-testing.html> Acesso em: 10 de outubro de 2021.

UDUGAMA, B.; KADHIRESAN, P.; KOZLOWSKI, H. N. MALEKJAHANI, A.; OSBORNE, M.; LI, V. Y. C.; CHEN, H.; MUBAREKA, S.; GUBBAY, J. B.; CHAN, W.

C. W. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano. 2020

VELOSO, A. C. C.; PEIXOTO, F. G. S. A importância da Biologia Molecular no diagnóstico de SARS-CoV-2. Revista Científica Multidisciplinar: O Saber - RCMOS, v. 3, n. 3, 2021. DOI: https://doi.org/10.51473/rcmos.v3i3.29

VIEIRA, L. M. F.; EMERY, E.; ANDRIOLO, A. COVID-19 - Diagnóstico Laboratorial para Clínicos. São Paulo: Scielo. 2020. DOI: https://doi.org/10.1590/SciELOPreprints.411

WANG, C.; HORBY, P. W.; HAYDEN, F. G.; GAO, G. F. A novel coronavirus outbreak of

global health concern. The Lancet, v. 395, n. 10223, p. 470-473, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30185-9

WANG, Q.; DU, Q.; GUO, B.; et al. A Method to Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays. Journal of Clinical Microbiology, v. 58, n. 6, p. 1-7, jun. 2020. DOI: https://doi.org/10.1128/JCM.00375-20

WANG, Y.; SUN, S.; SHEN, H.; et. al. Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases. Cellular & Molecular Immunology, v. 1, n. 4, p. 304-307, 2004.

WHO. Advice on the use of point-of-care immunodiagnostic tests for COVID-19. 2020. p. 2–3. Disponível em: <https://www.who.int/news-room/commentaries/ detail/advice-on-the- use- of-point-of-care-immunodiagnostic-tests-for-covid-19> Acesso em: 10 de outubro de 2021.

WHO. Immunity passports” in the context of COVID-19. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/331866/WHO-2019-nCoV-Sci_Brief- Immunity_passport-2020.1-eng.pdf?sequence=1&isAllowed=y

WHO-World Health Organization. Laboratory testing for 2019 novel coronavirus (2019- nCOV) in suspected human cases. 2020 Disponível em:

<https://www.who.int/publications/i/item/laboratorytesting-of-2019-novel-coronavirus-(- 2019-ncov)-in-suspectedhuman-cases-interim-guidance> Acesso em: 10 de outubro de 2021. DOI: https://doi.org/10.13070/mm.en.10.2867

WOLOSHIN, S.; PATEL, N.; KESSELHEIM, A. S. False Negative Tests for SARS-CoV-2

Infection — Challenges and Implications. The New England Journal of Medicine: Research & Review, v. 383, n. 6, p. 38, 2020. DOI: https://doi.org/10.1056/NEJMp2015897

WORLDOMETER. COVID-19 Coronavirus Pandemic: Confirmed Cases and Deaths by Country, Territory, or Conveyance. 2020. Disponível em: https://www.worldometers.info/coronavirus/#countries. Acesso em: 20 de setembro de 2021.

WU, C.; LIU, Y.; YANG, Y.; et. al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, v. 10, n. 5, p. 766-788, may, 2020. DOI: https://doi.org/10.1016/j.apsb.2020.02.008

WU, J.; WU, X.; ZENG, W.; et. al. Chest CT Findings in Patients with Coronavirus Disease 2019 and Its Relationship with Clinical Features. Investigative radiology, v. 55, n. 5, p. 257– DOI: https://doi.org/10.1097/RLI.0000000000000670

, 2020.

WU, Z.; MCGOOGAN, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323, n. 13, p. 1239 - 1242, 2020. DOI: https://doi.org/10.1001/jama.2020.2648

XAVIER, A. R. SILVA, J. S. ALMEIDA, J. P. C. L. CONCEIÇÃO, J. F. F. LACERDA, G.

KANAAN, S. COVID-19: manifestações clinicas e laboratoriais na infecção pelo novo coronavirus. Jornal Brasil Patologia Medicina Laboratorial, v. 56, p. 1-9, 2020.

YAN, G.; LEE, C. L.; LAM, L. T.; et al. Covert COVID-19 and false-positive dengue serology in Singapore. The Lancet Infectious Diseases, v. 20, n. 5, p. 536, 2020. DOI: https://doi.org/10.1016/S1473-3099(20)30158-4

YING, L.; PING, L.; BO, D.; et. al. Diagnostic Indexes of a Rapid IgG/IgM Combined Antibody Test for SARS-CoV-2. MedRxiv. 2020; Disponível em: DOI: https://doi.org/10.1101/2020.03.26.20044883

<https://www.medrxiv.org/content/10.1101/2020.03.26.20044883v1.full.pdf> Acesso em: 10 de outubro de 2021.

ZAIDI, M. B.; BARRON, L. C.; ALMEIDA, M. E. G.; et al. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population. Acta Tropica - Journals, v. 201, 2020. DOI: https://doi.org/10.1016/j.actatropica.2019.105201

ZHANG, W.; QIAN, B. Making decisions to mitigate COVID-19 with limited knowledge.

The Lancet Infectious Diseases, v. 20, n. 10, p. 1121-1122, 2020. DOI: https://doi.org/10.1016/S1473-3099(20)30280-2

ZHENG, J. SARS-coV-2: An emerging coronavirus that causes a global threat. International Journal of Biological Sciences, vol. 16, no. 10, p. 1678–1685, 2020. DOI: https://doi.org/10.7150/ijbs.45053

ZHOU, F.; YU, T.; DU, R.; et. al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, v. 395, n. 10229, p. 1054-1062, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

ZHU, N.; ZHANG, D.; WANG, W.; et. al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, v. 382, p. 727-733, 2020. DOI: https://doi.org/10.1056/NEJMoa2001017

ZOU, L.; RUAN, F.; HUANG, M.; et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. New England Journal of Medicine, v.382, n. 12, p. 1177- 1179, 2020. DOI: https://doi.org/10.1056/NEJMc2001737

ZUMLA, A.; CHAN, J. F. W.; AZHAR, E. I.; et. al. Coronaviruses—drug discovery and therapeutic options. Nature Reviews Drug Discovery, v. 15, n. 5, p. 327-347, 2016. DOI: https://doi.org/10.1038/nrd.2015.37

Published

2023-10-31

Issue

Section

Artigos